Brind.

Cytek Biosciences, headquartered in Fremont, participated in a UBS Precision Medicine Summit and a Morgan Stanley conference in August 2025.

2 reports, 1 independent Updated Aug 13

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cytek Biosciences, headquartered in Fremont, participated in a UBS Precision Medicine Summit and a Morgan Stanley conference in August 2025.

Who's involved

What this event is mainly about

Cytek Biosciences

Keep exploring

The entities involved

Cytek Biosciences
biotechnology company and producer of scientific instruments
- The Aurora platform successfully enabled marker analysis per sample, leading to Cytek Biosciences gaining market share due to its usability and pricing.Wed 23:07
- Cytek Biosciences' cloud platform is now accessible on Mac and PC devices.Wed 23:07

Related events

Cytek Biosciences operates within the Life Sciences industry.Jun 7

Coverage

Newest first; wire copies grouped

Aug 13GlobeNewswireCytek Biosciences to Participate in Upcoming Investor Conferences FREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company,
Jul 24GlobeNewswireCytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025 FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq